The Global Impact of Cancer
Cancer is a major public health challenge with significant social and economic burdens. According to the World Health Organization (WHO, 2023):
- Nearly 20 million new cancer cases were diagnosed globally in 2022.
- Cancer accounts for 1 in 6 deaths worldwide, making it the second leading cause of death after cardiovascular diseases.
- The most commonly diagnosed cancers are lung, breast, colorectal, stomach, and prostate cancer.
- Around 70% of cancer deaths occur in low- and middle-income countries, reflecting disparities in access to diagnostics and treatments.
Epidemiology by Region
- North America and Europe: High incidence of breast, prostate, and colorectal cancers, with strong screening and early detection programs.
- Asia: Rising incidence of lung, stomach, and liver cancers linked to lifestyle, diet, and infection-related risk factors.
- Africa: High mortality rates due to late diagnosis and limited healthcare resources, with cervical and liver cancers being prevalent.
- Latin America: Increasing cases of breast and colorectal cancer, often diagnosed at advanced stages.
Cancer Diagnostics Techniques
Overview:
From Detection to Precision Medicine
Early and accurate cancer diagnosis is critical for improving survival rates and guiding effective treatment strategies. Modern cancer diagnostic techniques combine classical approaches with advanced molecular tools, enabling clinicians and researchers to detect malignancies at earlier stages, classify tumor types, and design more personalized interventions.
Traditional methods such as biopsy, medical imaging, and histopathology remain the gold standard, providing direct evidence of tumor presence and morphology. However, these techniques are increasingly complemented by molecular and cellular assays that deliver deeper insights into cancer biology.
Current Diagnostic Approaches
Biopsy and Histopathology
Tissue sampling followed by microscopic examination remains the cornerstone of cancer diagnosis, offering definitive evidence of malignancy and tumor grading.Read more
Imaging Modalities
Techniques such as MRI, CT scans, PET scans, and ultrasound are used to localize tumors, assess progression, and monitor response to therapy. Read more
Molecular Profiling
DNA sequencing, RNA expression analysis, and proteomics uncover genetic mutations and biomarkers that drive tumor growth, forming the basis of personalized cancer medicine. Read more
Advanced and Emerging Techniques
Modern biotechnology has introduced innovative platforms that enhance diagnostic accuracy and reduce turnaround times:
Flow Cytometry
Enables rapid cell-by-cell analysis, distinguishing cancerous from healthy cells based on surface markers and cellular properties. Widely used in leukemia and lymphoma diagnosis.
Read more
PCR-based Detection Polymerase Chain Reaction (PCR)
allows the amplification and detection of oncogenes, tumor suppressor mutations, and viral DNA associated with cancers.Read more
ELISA (Enzyme-Linked Immunosorbent Assay)
A powerful immunoassay used to detect circulating tumor biomarkers (PSA, CA-125, CEA) in patient blood samples, aiding in early detection and disease monitoring.
Next-Generation Sequencing (NGS)
High-throughput sequencing provides comprehensive genetic profiling, identifying mutations, gene fusions, and microsatellite instability.Read more
Liquid Biopsy
A non-invasive technique analyzing circulating tumor DNA (ctDNA) and exosomes from blood samples, offering real-time monitoring of tumor evolution.Read more
Our latest content
Check out what's new in our company !
What Are Peptide Vaccines?
Mechanism of Action
The effectiveness of peptide vaccines lies in their ability to train the immune system:
01
Once administered, peptides are taken up by antigen-presenting cells (APCs) such as dendritic cells.Read more
02
These peptides are displayed on the surface of APCs bound to major histocompatibility complex (MHC) molecules.Read more
03
The peptide MHC complexes activate cytotoxic T lymphocytes (CTLs), also known as killer T cells.Read more
04
Activated CTLs then seek and destroy cancer cells that express the same peptide sequence on their surface.
FAQ Green Peptide
In this section, you can address common questions efficiently.
A peptide vaccine is based on short fragments of proteins (peptides) that mimic tumor antigens. They train the immune system to specifically recognize and target cancer cells.
Unlike classical vaccines that use whole or attenuated pathogens, peptide vaccines use precise amino acid sequences. This provides higher specificity, improved safety, and the potential for personalization.
- High specificity and purity
- Chemical stability and easy handling
- Multiple applications: diagnostics, immunology, biomarker discovery, and translational research
Peptides function as biomarkers and are integrated into assays such as ELISA, flow cytometry, and multiplex kits. They enable earlier and more reliable detection of cancer and other diseases by identifying unique molecular signatures.
Yes. We provide:
- Custom peptide synthesis
- Bioinformatics-driven peptide design for epitope mapping and vaccine research
- Tailored diagnostic kits designed to meet laboratory needs
Every peptide is manufactured under strict standards, including:
- GMP-grade production (when required)
- Quality control with HPLC and mass spectrometry
- Full batch traceability and documentation
We are committed to eco-friendly production, including:
- Reduced solvent and waste generation
- Energy-efficient processes
- Ethically sourced raw materials
